1. Home
  2. SDGR vs USPH Comparison

SDGR vs USPH Comparison

Compare SDGR & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • USPH
  • Stock Information
  • Founded
  • SDGR 1990
  • USPH 1990
  • Country
  • SDGR United States
  • USPH United States
  • Employees
  • SDGR N/A
  • USPH N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • USPH Medical/Nursing Services
  • Sector
  • SDGR Health Care
  • USPH Health Care
  • Exchange
  • SDGR Nasdaq
  • USPH Nasdaq
  • Market Cap
  • SDGR 1.8B
  • USPH 1.3B
  • IPO Year
  • SDGR 2020
  • USPH 1992
  • Fundamental
  • Price
  • SDGR $21.93
  • USPH $76.96
  • Analyst Decision
  • SDGR Buy
  • USPH Strong Buy
  • Analyst Count
  • SDGR 7
  • USPH 4
  • Target Price
  • SDGR $32.29
  • USPH $111.50
  • AVG Volume (30 Days)
  • SDGR 1.1M
  • USPH 130.7K
  • Earning Date
  • SDGR 04-30-2025
  • USPH 05-06-2025
  • Dividend Yield
  • SDGR N/A
  • USPH 2.34%
  • EPS Growth
  • SDGR N/A
  • USPH 43.97
  • EPS
  • SDGR N/A
  • USPH 1.84
  • Revenue
  • SDGR $207,539,000.00
  • USPH $664,433,000.00
  • Revenue This Year
  • SDGR $28.69
  • USPH $14.00
  • Revenue Next Year
  • SDGR $14.95
  • USPH $6.39
  • P/E Ratio
  • SDGR N/A
  • USPH $41.79
  • Revenue Growth
  • SDGR N/A
  • USPH 10.99
  • 52 Week Low
  • SDGR $16.67
  • USPH $76.18
  • 52 Week High
  • SDGR $29.15
  • USPH $113.63
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 47.81
  • USPH 30.99
  • Support Level
  • SDGR $19.48
  • USPH $78.25
  • Resistance Level
  • SDGR $21.90
  • USPH $83.95
  • Average True Range (ATR)
  • SDGR 1.65
  • USPH 3.17
  • MACD
  • SDGR -0.04
  • USPH -0.50
  • Stochastic Oscillator
  • SDGR 51.20
  • USPH 4.90

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About USPH U.S. Physical Therapy Inc.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Share on Social Networks: